Skip to content

Feasibility of a Modular mHealth for Tailored Rehabilitation of Breast Cancer

Feasibility of a Modular mHealth for Tailored Rehabilitation During the Treatment of Breast Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04781712
Acronym
MMHTR
Enrollment
44
Registered
2021-03-04
Start date
2019-04-22
Completion date
2021-03-30
Last updated
2022-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

This study investigated the feasibility of the novel modular mobile health (mHealth) for personalized rehabilitation and explored the participants' satisfaction and app data during treatment of breast cancer.

Detailed description

This is prospective, feasible, parallel study in post-operative patients with breast cancer and during treatment. Disability of Arm, Shoulder, Hands (DASH), Physical activity data (IPAQ-SF), Physical measurement such as hand grip strength, body mass index (BMI), muscle mass, and differences in arm circumference, PRO-CTCAE, Distress Thermometer, needs and satisfaction in app, personal health record of app (exercise, daily step count, etc.) Measure will be evaluated on 1-month, 2-month, 4-month, 6-month, 9-month, and 12-month after POD.

Interventions

BEHAVIORALModular mHealth for Tailored Rehabilitation

an individually tailored self-management through the mHealth app with a smart band worn on the wrist

Sponsors

Samsung Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Unilateral breast cancer at TNM stage 0 \ III * Patients who will undergo the treatment (chemotherapy, radiation therapy, and hormone therapy) after surgery * Patients who had a mobile phone (Android or iOS)

Exclusion criteria

\- Patients who have metastases or recurrence to other organs were excluded

Design outcomes

Primary

MeasureTime frameDescription
satisfaction score in app contents1 to 12monthsatisfaction score in app contents, Likert scale (5-point, higher scores mean a better)
Needs score in app contents1 to 12monthNeeds score in app contents, Likert scale (5-point, higher scores mean a better)
DASH (Disabilities of Arm, Shoulder, Hands)1 month, 2month, 4month, 6month, 9month, 12monthChange from Baseline DASH score at 12 months, higher scores mean a worse (0-100)

Secondary

MeasureTime frameDescription
Physical measurement (upper extremity volume)1 to 12monthdifferences in arm circumference
Physical activity (IPAQ-SF Questionnaire)1 to 12monthTotal METs within recent 7 days (vigorous, moderate, walking, sitting), higher values mean a better
PRO-CTCAE (patients reported outcomes)1 to 12monthSymptoms during treatment
Distress thermometer (distress level)1 to 12monthDistress level during treatment, higher scores mean a worse (0-10)
Physical measurement (handgrip strength)1 to 12monthHandgrip strength (kg)
App use data (personal health record)_Physical activity change1 to 12monthdaily step count (number), higher values mean a better physical activity
App use data (personal health record)_interest of contents1 to 12monthcontents view (number), higher values mean a better compliance rate
App use data (personal health record)_sleep1 to 12monthsleep compliance rate (%), higher values mean a better compliance rate
App use data (personal health record)_Exercise compliance rate1 to 12monthExercise time, higher values mean a better
Physical measurement (of body composition, BMI)1 to 12monthBody mass index
Physical measurement (of body composition, muscle mass)1 to 12monthmuscle mass

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026